keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CGP 20712 A (CGP 20712 mesylate) is a selective and potent β1-adrenergic receptor antagonist (IC50: 0.7 nM) with antihypertensive activity that reverses RKT-induced gastric relaxation.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 34,000 | |||
5 mg | 在庫あり | ¥ 85,500 | |||
10 mg | 在庫あり | ¥ 126,000 | |||
25 mg | 在庫あり | ¥ 199,500 | |||
50 mg | 在庫あり | ¥ 268,500 | |||
100 mg | 在庫あり | ¥ 360,500 |
説明 | CGP 20712 A (CGP 20712 mesylate) is a selective and potent β1-adrenergic receptor antagonist (IC50: 0.7 nM) with antihypertensive activity that reverses RKT-induced gastric relaxation. |
ターゲット&IC50 | β1-adrenoceptor:0.7 nM , β1-adrenoceptor:0.7 nM |
In vitro | In myocyte, saturation experiments conducted in the presence of 300nM CGP 20712A failed to detect specific binding of [125I]-ICYP and [3H]-CGP 12177[2]. |
In vivo | Pre-treatment with 5mg/kg CGP 20712A (selective β1-adrenoceptor antagonist) in 8-day-old rats did not alter the plasma ACTH response to insulin injection[3]. |
別名 | CGP 20712 mesylate |
分子量 | 590.57 |
分子式 | C24H29F3N4O8S |
CAS No. | 105737-62-0 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (135.46 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGP 20712 A 105737-62-0 GPCR/G Protein Neuroscience Adrenergic Receptor CGP-20712 Mesylate CGP20712 Mesylate CGP 20712 mesylate Inhibitor inhibitor inhibit